[Clinical and laboratory criteria for assessing the efficacy of Essliver Forte for patients with combined liver and gall bladder pathologies].

@article{Kozlova2006ClinicalAL,
  title={[Clinical and laboratory criteria for assessing the efficacy of Essliver Forte for patients with combined liver and gall bladder pathologies].},
  author={Irina Kozlova and A A Antonian and Sergei Volkov},
  journal={Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology},
  year={2006},
  volume={4},
  pages={31-6, 115-6}
}
As many as 60 patients with combined pathologies (chronic hepatitis (CH) and chronic non-calculous cholecystitis (CNCC)) were examined, and 20 healthy subjects were included in the control group. The efficacy of Essliver Forte for patients with chronic non-calculous cholecystitis combined with chronic hepatitises (both viral hepatitis and steatohepatitis… CONTINUE READING